Paradigm Biocapital Advisors »

Ambrx Biopharma shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $64M 4.5M 14.24

More positions owned by Paradigm Biocapital Advisors

Nuvalent Inc-a (NUVL)
Arcellx Common Stock (ACLX)
Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Crinetics Pharmaceuticals In (CRNX)
Sarepta Therapeutics (SRPT)
Immunocore Hldgs Ads (IMCR)
Legend Biotech Corp Sponsored Ads (LEGN)
Arvinas Ord (ARVN)
Xenon Pharmaceuticals (XENE)
Tarsus Pharmaceuticals (TARS)
Cerevel Therapeutics Hldng I (CERE)
Revolution Medicines (RVMD)
Olema Pharmaceuticals (OLMA)
Miragen Therapeutics (VRDN)

View all positions for Paradigm Biocapital Advisors

Top funds holding Ambrx Biopharma

Federated Investors
Alliancebernstein
Altitude Crest Partners
Virtu Financial

View all funds holding Ambrx Biopharma